Biotech groups slam Malaysia, Canada and Korea in Special 301 comments
20-02-2018
Blan-k / Shutterstock.com
The Biotechnology Innovation Organization (BIO) has welcomed the US Trade Representative’s (USTR) “Special 301 Report”, which it said “aims to advance global IP rights in biotechnology in a number of constructive ways”.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Biotechnology Innovation Organization, BIO, US Trade Representative, USTR, Special 301 Report, biotechnology, patent
